Precision medicine offers the possibility of more specific therapeutic treatment options leading to
greater potential for success with less toxicity. However, true precision medicine requires the type
of patient information that is currently unavailable using either classical single marker IHC
testing or flow-cytometry with its accompanying loss of tissue context.
Whether you are a pharmaceutical company, CRO, IVD manufacturer, reference lab, or hospital-based
laboratory interested in developing companion diagnostics (CDx), laboratory tests for clinical
trials, or tests as standard of care, Cell IDx can help provide the type of precise information you
need. Our UltraPlex mxIF technology allows multiplexing of four or more tissue markers
and by combining sequential sections with UltraPlex mxIF, one can interrogate up to 12 markers.
Please contact us to discuss your needs with a call or email, or complete the form below.